Recent Posts on This Topic | See All >
[Source: KPHO] - Scientific researchers in the Valley have high hopes for new therapies for patients with certain types of cancer.
New drugs are constantly in development at the Translational Genomics Research Institute, also known as TGen, based in Phoenix. But some of the clinical trials to test these new drugs could be at risk if more cancer patients don’t get involved in the studies.
In collaboration with the Virginia G. Piper Cancer Center at Scottsdale Healthcare, TGen has about 35 clinical trials under way. These trials test the safety and effectiveness of the new drugs prior to approval by the U.S. Food and Drug Administration.
For more informaton: Medical Clinical Trials Face Obstacles
Now available: “Action and Impact," a 2014 report on the grant programs and activities of the Flinn Foundation in Arizona biosciences, civic leadership, arts and culture, and the Flinn Scholars program.